Sanofi announces changes to its Executive Committee
Brian Foard will lead the Specialty Care GBU ad interim, effective immediately.
Brian Foard will lead the Specialty Care GBU ad interim, effective immediately.
Dupixent peak sales ambition raised to more than €13 billion
Nexviazyme specifically targets the M6P receptor, the key pathway for enzyme replacement therapy, to effectively clear glycogen build-up in muscle cells
Subscribe To Our Newsletter & Stay Updated